Howard Capital Management (New York)’s Pfizer PFE Stock Holding History

Howard Capital Management (New York)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$248K	Buy	6,735 +184	+3%	+$6.75K	0.03%	81
2020 Q3	$228K	Sell	6,551 -79,727	-92%	-$2.8M	0.03%	77
2020 Q2	$2.68M	Hold	86,278	–	–	0.36%	40
2020 Q1	$2.67M	Sell	86,278 -633	-0.7%	-$21.6K	0.46%	38
2019 Q4	$3.23M	Hold	86,911	–	–	0.4%	45
2019 Q3	$2.96M	Hold	86,911	–	–	0.42%	43
2019 Q2	$3.57M	Sell	86,911 -1,946	-2%	-$77.3K	0.49%	44
2019 Q1	$3.58M	Sell	88,857 -305	-0.3%	-$12.2K	0.51%	44
2018 Q4	$3.69M	Sell	89,162 -318	-0.4%	-$13.2K	0.61%	45
2018 Q3	$3.74M	Sell	89,480 -512	-0.6%	-$19.7K	0.5%	47
2018 Q2	$3.1M	Buy	89,992 +201	+0.2%	+$6.87K	0.45%	46
2018 Q1	$3.02M	Hold	89,791	–	–	0.44%	46
2017 Q4	$3.09M	Hold	89,791	–	–	0.45%	47
2017 Q3	$3.04M	Hold	89,791	–	–	0.47%	48
2017 Q2	$2.86M	Sell	89,791 -1,465	-2%	-$46.2K	0.45%	50
2017 Q1	$2.96M	Buy	91,256 +1,412	+2%	+$44.5K	0.49%	47
2016 Q4	$2.77M	Hold	89,844	–	–	0.49%	47
2016 Q3	$2.89M	Hold	89,844	–	–	0.52%	46
2016 Q2	$3M	Buy	89,844 +54	+0.1%	+$1.72K	0.58%	45
2016 Q1	$2.52M	Buy	89,790 +1,224	+1%	+$35K	0.5%	46
2015 Q4	$2.71M	Hold	88,566	–	–	0.53%	45
2015 Q3	$2.64M	Hold	88,566	–	–	0.54%	45
2015 Q2	$2.82M	Hold	88,566	–	–	0.54%	48
2015 Q1	$2.92M	Buy	88,566 +733	+0.8%	+$23.3K	0.56%	46
2014 Q4	$2.6M	Hold	87,833	–	–	0.5%	48
2014 Q3	$2.46M	Hold	87,833	–	–	0.49%	47
2014 Q2	$2.47M	Sell	87,833 -211	-0.2%	-$6.01K	0.49%	49
2014 Q1	$2.68M	Sell	88,044 -86	-0.1%	-$2.56K	0.53%	48
2013 Q4	$2.56M	Buy	88,130 +86	+0.1%	+$2.5K	0.53%	47
2013 Q3	$2.4M	Sell	88,044 -21	-0%	-$571	0.59%	43
2013 Q2	$2.34M	Buy	+88,065	New	+$2.43M	0.61%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Howard Capital Management (New York)'s PFE Position: Q4 2020 in Review

Howard Capital Management (New York) increased its Pfizer (PFE) stake by 2.8% in Q4 2020, buying an estimated $6.75K and bringing the position to 6,735 shares worth $248K. The position accounts for 0.03% of the portfolio, ranked #81.

Howard Capital Management (New York) first reported a position in PFE in Q2 2013 and has held it in 31 quarters since. The position peaked at $3.74M in Q3 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Howard Capital Management (New York) held 6,735 shares of Pfizer worth $248K as of Q4 2020.
Howard Capital Management (New York) bought 184 Pfizer shares in Q4 2020, an estimated $6.75K.
Pfizer made up 0.03% of Howard Capital Management (New York)'s portfolio in Q4 2020, its #81 holding.
Howard Capital Management (New York) first reported a position in Pfizer in Q2 2013 and has held it in 31 quarters since.
Howard Capital Management (New York)'s Pfizer position peaked at $3.74M in Q3 2018.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Howard Capital Management (New York)'s 13F filing for Q4 2020, filed 2 Feb 2021.